Atlas Trials

A Phase II Study of Lonsurf (TAS-102) in Metastatic Platinum and Checkpoint Inhibitor-resistant Bladder Cancer

Clinical trial NCT03762161 · UNKNOWN

Trial details

NCT number
NCT03762161
Sponsor
Rahul Parikh
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Bladder Cancer
Start date
2019-01-03
Primary completion
2023-07-01
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.